Innovative payment systems for medicines in Europe

被引：0

|

作者：

Rutten, Frans F. H. ^{[1
]}

Uyl-de Groot, Carin A. ^{[1
]}

Vulto, Arnold G. ^{[2
]}

机构：

[1] Erasmus Univ, Erasmus MC, Dept Hlth Policy & Management, Inst Med Technol Assessment, NL-3000 DR Rotterdam, Netherlands

[2] Erasmus Univ, Med Ctr, Dept Hosp Pharm, NL-3015 CE Rotterdam, Netherlands

来源：

EJHP PRACTICE | 2009年 / 15卷 / 03期

关键词：

D O I：

暂无

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

收藏

页码：60 / 62

页数：3

相关论文

共 50 条

[1] Access to innovative oncology medicines in Europe
Bergmann, L.
Enzmann, H.
Thirstrup, S.
Schweim, J. K.
Widera, I.
Zwierzina, H.
ANNALS OF ONCOLOGY, 2016, 27 (02) : 353 - 356
[2] Impediments to the diffusion of innovative medicines in Europe
Oliver Schöffski
PharmacoEconomics, 2004, 22 : 51 - 64
[3] Impediments to the diffusion of innovative medicines in Europe
Schöffski, O
PHARMACOECONOMICS, 2004, 22 (Suppl 2) : 51 - 64
[4] Access to innovative medicines in Europe: An overview
Sekulovic, L. K.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2017, 31 : 31 - 31
[5] Payment for medicines
不详
LANCET, 1938, 2 : 807 - 807
[6] The use of innovative payment mechanisms for gene therapies in Europe and the USA
Jorgensen, Jesper
Kefalas, Panos
REGENERATIVE MEDICINE, 2021, 16 (04) : 405 - 422
[7] PAYMENT FOR MEDICINES IN AUSTRALIA
DAMPNEY, MJ
LANCET, 1952, 263 (NOV1): : 879 - 879
[8] Editorial: Hospital case payment systems in Europe
Busse R.
Schreyögg J.
Smith P.C.
Health Care Management Science, 2006, 9 (3) : 211 - 213
[9] Will the Innovative Medicines Initiative really deliver innovative medicines?
Wilkinson, Emma
MOLECULAR ONCOLOGY, 2008, 2 (03) : 203 - 205
[10] Europe provides (sic)172m for research into innovative medicines
Watson, Rory
BRITISH MEDICAL JOURNAL, 2011, 342

← 1 2 3 4 5 →